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Abstract
Objective: As part of the American College of Cardiology Adult Congenital and Pediatric Cardiol-
ogy Section effort to develop quality metrics (QMs) for ambulatory pediatric practice, the chest
pain subcommittee aimed to develop QMs for evaluation of chest pain.
Design: A group of 8 pediatric cardiologists formulated candidate QMs in the areas of history,
physical examination, and testing. Consensus candidate QMs were submitted to an expert panel
for scoring by the RAND-UCLA modified Delphi process. Recommended QMs were then available
for open comments from all members.
Patients: These QMs are intended for use in patients 5–18 years old, referred for initial evaluation
of chest pain in an ambulatory pediatric cardiology clinic, with no known history of pediatric or
congenital heart disease.
Results: A total of 10 candidate QMs were submitted; 2 were rejected by the expert panel, and 5
were removed after the open comment period. The 3 approved QMs included: (1) documentation
of family history of cardiomyopathy, early coronary artery disease or sudden death, (2) perform-
ance of electrocardiogram in all patients, and (3) performance of an echocardiogram to evaluate
coronary arteries in patients with exertional chest pain.
Conclusions: Despite practice variation and limited prospective data, 3 QMs were approved, with
measurable data points which may be extracted from the medical record. However, further pro-
spective studies are necessary to define practice guidelines and to develop appropriate use criteria
in this population.
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1 | INTRODUCTION
Chest pain is a common referral diagnosis for ambulatory pediatric
cardiology evaluation.1–3 However, the majority of these patients do
not have cardiac causes of chest pain.2–4 In a cohort of 3700
patients with median follow-up of 4.4 years, a cardiac cause was
identified in only 37 cases (1%), with no cardiac deaths.2 Unfortu-
nately, there are few prospective studies and no validated practice
guidelines to inform practice, and children presenting with a
complaint of chest pain may undergo extensive evaluation with sig-
nificant practice variation.5
The American College of Cardiology (ACC) Adult Congenital and
Pediatric Cardiology Council (ACPC) recognized the need to develop
quality metrics (QMs) in 5 key areas of pediatric and congenital heart
disease.6 The Chest Pain subcommittee aimed to develop QMs for
evaluation of chest pain in children. This article reviews the process of
quality metric development, a summary of candidate and approved
QMs, and a discussion of key issues that arose during the process.
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2 | METHODS
The team consisted of 8 pediatric cardiologists from the United States,
including a team leader. Beginning in September 2012, initial confer-
ence calls discussed the scope of the project, with identification of key
areas for evaluation. The patient population was identified as patients
ages 5–18 years, seen for an initial consultation at an ambulatory pedi-
atric cardiology clinic with a chief complaint of chest pain. Candidate
QMs were not intended to encompass patients with a previous diagno-
sis of acquired or congenital heart disease or patients presenting to an
emergency room or inpatient setting.
Three categories were identified: history, physical examination,
and testing. The team was then divided into subgroups of 2–3 cardiolo-
gists, each with a subgroup lead, to evaluate the existing literature and
to formalize candidate QMs within their respective category. The QMs
included a description of the proposed metric, numerator, denominator,
and exclusions. All resulting QMs were discussed at conference calls
involving the entire team. QMs were evaluated for clinical relevance,
ease of measurement, and feasibility for widespread application.
The formalized QMs were subsequently evaluated by an expert
panel from the ACC ACPC section using the RAND-UCLA modified Del-
phi process7 in two rounds of voting (first, individually, and second, in an
in-person meeting).6 Metrics were scored for validity and feasibility on a
scale of 1 to 9, with 9 having the highest validity and feasibility. QMs
with a mean validity 7 to 9 and median feasibility 4 to 9 were approved.
Approved QMs were then posted on the ACC website for a 4-week
open comment period, with comments solicited from all members. All
comments were reviewed by the expert panel, for final approval of QMs.
3 | RESULTS
3.1 | Literature review
Although there are no validated practice guidelines, a Standardized
Clinical Assessment and Management Plan (SCAMP) for chest pain was
developed at Boston Children’s Hospital,4 which has been shown to
decrease practice variation and resource utilization,4,5 and has been
extended to other centers in the region.8 This algorithm utilizes ele-
ments of history (exertional chest pain with no alternative explanation,
concerning past medical or family history), abnormal physical exam, or
abnormal electrocardiogram to determine which patients should
undergo further evaluation with echocardiography. The SCAMP has
not been endorsed by a governing organization, and differs from clini-
cal practice guidelines in that data are analyzed on a recurring basis,
allowing for ongoing revision of the SCAMP.
Guidelines not specific to chest pain were also considered. The
American Heart Association (AHA) Scientific Statement on cardiovas-
cular risk in high-risk pediatric patients includes family history of early
coronary artery disease for risk stratification.9 In addition, the AHA Sci-
entific Statement on preparticipation sports evaluation recommends
evaluation of family history for hypertrophic cardiomyopathy, dilated
cardiomyopathy, and sudden cardiac death.10
The existing literature on chest pain in children consists largely of
retrospective cohort studies. Although chest pain is a common indica-
tion for referral to a pediatric cardiologist, cardiac causes are rare.2–4,11
Among patients with cardiac conditions which could cause chest pain,
the most common diagnosis was a coronary artery anomaly, with 70%
presenting with exercise-induced chest pain.11 Echocardiography is the
test of choice for initial evaluation of coronary artery anomalies.12 The
electrocardiogram can be abnormal in cardiac causes of chest
pain,11,13,14 and has a high negative predictive value for hypertrophic
cardiomyopathy, long QT syndrome, and Wolff-Parkinson-White syn-
drome.15 However, rhythm recording devices (RRD; such as Holter
monitors and event recorders) have not demonstrated benefit in
patients with isolated chest pain.4,16 Exercise stress test (EST) for chest
pain is typically negative,1,2,4,17,18 and can even be negative in patients
with documented coronary artery anomalies.19,20
3.2 | QM
Consensus was reached for 10 candidate QMs (Table 1), with 3 based
on history, 1 on physical examination, and 6 on testing. Due to the rar-
ity of positive findings, improved quality care and cost effectiveness
may be reflected in the absence rather than in the performance of fur-
ther testing. Thus, instead of measuring the proportion of patients who
received an appropriate test or documentation, 3 candidate QMs (4, 6,
and 7) evaluated the proportion of patients who had testing performed
under inappropriate conditions. For these measures, optimal care
would be reflected in a lower rather than higher percentage of tests
performed. However, in the absence of accepted appropriate use crite-
ria, there was concern in the group that adoption of such QMs may be
premature, and could be interpreted as establishing new guidelines.
After the RAND process, two history-based metrics (history of
fever and history of Kawasaki disease) did not pass due to inadequate
validity. Validity and feasibility scores were previously reported.6
The highest attrition of QMs occurred after the open comments
and final review by the steering committee, during which 5 of 8 metrics
were rejected. The physical examination QM (palpation of the chest
wall) was rejected due to comments that it was not a reliable method to
exclude cardiac disease. Although this maneuver is commonly used,
reproducible pain to palpation does not exclude the possibility of an
additional cause of cardiac chest pain, such as myocarditis. Similarly,
QMs 4, 6, and 7, intended to evaluate for inappropriate testing, were
rejected due to concerns for overlap of symptoms in this age group (eg,
having both musculoskeletal chest pain as well as cardiac pathology).
These QMs could potentially limit physicians in pursuing additional test-
ing which may be appropriate in the context of other clinical signs and
symptoms. In addition, QMs evaluating exercise treadmill test were
deferred, due to comments regarding the ambiguity of exercise stress
testing (eg, electrocardiogram or echocardiogram). Stress echocardiogra-
phy may be a useful adjunct in evaluation of exertional chest pain in
some patients. Due to the ambiguity and potential controversy, these
QMs thus could not yet be approved as indicators of quality care.
Thus, after the RAND process and open comments period, 3 QMs
were approved for children ages 5–18 years with an initial presentation
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of chest pain to an outpatient pediatric cardiology clinic: (1) evaluation
of family history, (2) electrocardiogram in all patients, and (3) echocar-
diogram for exertional chest pain.
4 | DISCUSSION
This process led to successful development of 3 QM for outpatient
evaluation of chest pain in children and adolescents. This is the first
ACPC quality metric effort to evaluate a symptom (chest pain), rather
than a diagnosis.
The frequency of chest pain referrals and broad variation of testing
patterns make chest pain in children an essential area for standardiza-
tion and improved quality of care. However, addressing a symptom
rather than an established diagnosis raises difficulties in the breadth of
patients and presentations. In children, symptoms may overlap signifi-
cantly. For example, although fever in the appropriate context may sug-
gest myocarditis, a potential cardiac cause of chest pain, it may be very
TABLE 1 Candidate QM for chest pain submitted to expert panel
Candidate measure
1. Family history
Numerator: Patients with documentation of positive or negative family history for cardiomyopathy, early coronary artery disease in a first-degree rel-
ative (male <55 years, female <65 years), or sudden cardiac death
Denominator: Patients 5–18 years old seen in ambulatory pediatric cardiology clinic with chief complaint of chest pain
Exclusions: None
2. Palpation of the chest wall
Numerator: Patients with documentation of palpation of the chest (eg, whether chest pain is reproducible) in the physical exam
Denominator: Patients 5–18 years old seen in ambulatory pediatric cardiology clinic with chief complaint of chest pain
Exclusions: None
3. Electrocardiogram
Numerator: Patients who had an ECG performed on the day of consultation or within one month of initial consultation for chest pain
Denominator: Patients 5–18 years old seen in ambulatory pediatric cardiology clinic with chief complaint of chest pain
Exclusions: None
4. No echocardiogram in pediatric patients with musculoskeletal chest pain
Numerator: Patients that had an echocardiogram performed or ordered on the day of the cardiology clinic visit
Denominator: Patients 5–18 years old seen in ambulatory pediatric cardiology clinic with clinical evidence of musculoskeletal chest wall pain (repro-
ducible to palpation over the costochondral junctions, chest wall, or under the costal margins)
Exclusions: Patients with exertional chest pain component, family history of sudden death or cardiomyopathy, or abnormal physical examination or
electrocardiogram findings
5. Echocardiogram for exertional chest pain
Numerator: Patients that had an echocardiogram performed or ordered on day of cardiology clinic visit that includes a comment regarding coronary
artery anatomy
Denominator: Patients 5–18 years old seen in ambulatory pediatric cardiology clinic for chief complaint of chest pain, with solely exertional chest
pain (eg, documentation of chest pain with exercise, but not at rest)
Exclusions: Previous echocardiogram or cardiac magnetic resonance or computed tomography within 6 months with documentation of coronary
artery anatomy, or chest pain characteristic of musculoskeletal chest pain or exercise-induced asthma
6. Appropriate use of RRD for chest pain
Numerator: Patients that had an RRD ordered
Denominator: Patients 5–18 years old seen in ambulatory pediatric cardiology clinic with chief complaint of isolated chest pain
Exclusions: Previous diagnosis of cardiomyopathy or arrhythmias
7. Utilization of EST in musculoskeletal chest pain
Numerator: Patients that had an EST performed or ordered on the day of the cardiology clinic visit
Denominator: Patients 5–18 years old seen in ambulatory pediatric cardiology clinic with clinical evidence of musculoskeletal chest wall pain (repro-
ducible to palpation over the costochondral junctions, chest wall, or under the costal margins)
Exclusions: Patients with exertional chest pain component, family history of sudden death or cardiomyopathy, or abnormal physical examination or
electrocardiogram findings
8. Appropriate use of EST in patients with exertional chest pain
Numerator: Patients with documentation in HPI or ROS of exertional chest pain or associated palpitations or syncope
Denominator: Patients 5–18 years old seen in ambulatory pediatric cardiology clinic for chief complaint of chest pain who had an EST performed or
ordered on the day of evaluation
Exclusions: Patients with exertional chest pain component, family history of sudden death or cardiomyopathy, or abnormal physical examination or
electrocardiogram findings
9. History of fever
Numerator: Patients with documentation of presence/absence of fever within the prior 30 days
Denominator: Patients 5–18 years old seen in ambulatory pediatric cardiology clinic with chief complaint of chest pain
Exclusions: None
10. History of Kawasaki disease
Numerator: Patients with documentation of presence/absence of a history of Kawasaki disease
Denominator: Patients 5–18 years old seen in ambulatory pediatric cardiology clinic with chief complaint of chest pain
Exclusions: None
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nonspecific due to the frequency of viral infections in this population,
and thus has insufficient validity to recommend as a quality metric. In
addition, although further testing in many cases of musculoskeletal
chest pain may be unnecessary, pain on palpation may not exclude an
additional diagnosis, and there may be other extenuating historical or
physical examination findings which would make additional testing rea-
sonable. The lack of established guidelines or appropriate use criteria
limits the ability to develop QMs that would help identify and evaluate
clinical practice variation. Development of such guidelines or appropri-
ate use criteria can be challenging since chest pain is a symptom rather
than a diagnosis. However, future efforts to establish clinical standards
and guidelines would be necessary to allow for additional QMs in the
future.
The recommended QM offer discrete and measurable data points
which can be extracted from the medical record, and should be docu-
mented in an appropriate evaluation of pediatric chest pain. The cur-
rent work differs from existing literature, as these metrics are designed
to be used as indicators of high quality patient care, rather than as an
algorithm or practice guideline. They are intended for use retrospec-
tively to assess adherence rather than prospectively to guide practice.
Thus, although several candidate QMs addressed aspects of care which
would typically be recommended, such as relevant history or palpation
for reproducible musculoskeletal chest pain, the metrics could only
include elements most closely aligned with existing published data, and
which can be easily measured retrospectively from appropriate
documentation.
There are limitations in this process. Although these metrics mea-
sure data points that are necessary for quality care, they are not suffi-
cient. They are necessarily narrow, as the dearth of accepted guidelines
and evidence prevents further reaching metrics of accepted quality.
These metrics are not intended to form a broader clinical practice
guideline or to address all potential testing for any given patient. The
practitioner is still encouraged to assess each patient as an individual.
The QMs are intended to evaluate clinical practice, not to refrain from
ordering tests that may be appropriate for a specific patient or clinical
scenario.
In conclusion, QM were developed for initial outpatient evalua-
tion of chest pain in 5- to 18-year-old patients. Family history of car-
diomyopathy, early coronary artery disease or sudden death should
be documented, electrocardiogram should be performed in all
patients, and an echocardiogram should be performed to evaluate
coronary arteries in patients with exertional chest pain. Further pro-
spective research is necessary to acquire more data as well as to
define practice guidelines and to develop appropriate use criteria in
this population. As guidelines and appropriate use criteria are cre-
ated and validated, further measures of quality care may be recom-
mended in future efforts.
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